Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
218 participants
INTERVENTIONAL
2014-01-31
2017-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Informing Decisions in Chronic Critical Illness: A Randomized Control Trial (RCT)
NCT01230099
Health Literacy Intervention for Informed Consent of Cancer Patients Considering Clinical Trial Participation
NCT01964222
Improving Quality With Outpatient Decision Support
NCT00225628
Patient Communication Training Intervention
NCT00933855
Assessment of Comskil Training Through Videorecording and Patient Surveys
NCT00943813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Support Outreach
Providers receive standard written screening recommendations and do not receive academic detailing (educational outreach)
Standard support
Screening recommendations presented in standard format
No academic detailing
Physician receives study orientation for not the academic detailing curriculum
Standard materials and academic detailing
Providers receive standard written screening recommendations and receive academic detailing (educational outreach)
Academic detailing
Educational outreach to address the rationale and data supporting recommendations for and against screening
Standard support
Screening recommendations presented in standard format
Color-coded materials and no academic detailing
Providers receive color-coded written screening recommendations and do not receive academic detailing (educational outreach)
Color-coded materials
A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation
No academic detailing
Physician receives study orientation for not the academic detailing curriculum
Color-coded materials and academic detailing
Providers receive color-coded written screening recommendations and receive academic detailing (educational outreach)
Color-coded materials
A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation
Academic detailing
Educational outreach to address the rationale and data supporting recommendations for and against screening
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Color-coded materials
A summary of treatment recommendations for each cancer screening is color-coded to indicate the strength and direction of the recommendation
Academic detailing
Educational outreach to address the rationale and data supporting recommendations for and against screening
Standard support
Screening recommendations presented in standard format
No academic detailing
Physician receives study orientation for not the academic detailing curriculum
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Providers: non-pediatric primary care physicians from Mount Sinai Beth Israel or St. Luke's-Roosevelt associated practices
Exclusion Criteria
* Inability to read and understand English
* Transgender status
30 Years
89 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beth Israel Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James A Talcott, MD SM
Role: PRINCIPAL_INVESTIGATOR
Mount Sinai Beth Israel
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Sinai Beth Israel
New York, New York, United States
St. Luke's-Roosevelt
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OGARA CAN-264
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.